Showing results (71-80 of 165) with videos related to

Sort By:
Pageof 17
Antimicrobial Agents and Chemotherapy|June 12, 2019
Pharmacokinetic/Pharmacodynamic Evaluation of Solithromycin against Streptococcus pneumoniae Using Data from a Neutropenic Murine Lung Infection ModelOlanrewaju O Okusanya, Alan Forrest, Sujata M Bhavnani, et al.
Diagnostic Microbiology and Infectious Disease|December 21, 2006
Serial sinus aspirate samples during high-dose, short-course levofloxacin treatment of acute maxillary sinusitisJack B Anon, Margaret Paglia, Jim Xiang, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2019
APX001 Pharmacokinetic/Pharmacodynamic Target Determination against <i>Aspergillus fumigatus</i> in an <i>In Vivo</i> Model of Invasive Pulmonary AspergillosisMiao Zhao, Alexander J Lepak, Karen Marchillo, et al.
Virulence|October 30, 2016
Pseudomonas aeruginosa proteolytically alters the interleukin 22-dependent lung mucosal defenseAntoine Guillon, Deborah Brea, Eric Morello, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 21, 2024
Piperacillin/Tazobactam Susceptibility Test Interpretive Criteria for Enterobacterales: Recommendations From the United States Committee on Antimicrobial Susceptibility TestingThomas P Lodise, Sujata M Bhavnani, Paul G Ambrose, et al.
The Journal of Infectious Diseases|December 28, 2006
Isoniazid's bactericidal activity ceases because of the emergence of resistance, not depletion of Mycobacterium tuberculosis in the log phase of growthTawanda Gumbo, Arnold Louie, Weiguo Liu, et al.
Diagnostic Microbiology and Infectious Disease|June 28, 2008
Pharmacokinetics-pharmacodynamics of quinolones against Streptococcus pneumoniae in patients with community-acquired pneumoniaSujata M Bhavnani, Alan Forrest, Jeffrey P Hammel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 23, 2007
Back to the future: using aminoglycosides again and how to dose them optimallyGeorge L Drusano, Paul G Ambrose, Sujata M Bhavnani, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2007
Isoniazid bactericidal activity and resistance emergence: integrating pharmacodynamics and pharmacogenomics to predict efficacy in different ethnic populationsTawanda Gumbo, Arnold Louie, Weiguo Liu, et al.
Frontiers in Microbiology|September 3, 2019
<i>Pseudomonas aeruginosa</i> Lipoxygenase LoxA Contributes to Lung Infection by Altering the Host Immune Lipid SignalingEric Morello, Teresa Pérez-Berezo, Chloé Boisseau, et al.
Pageof 17